Spots Global Cancer Trial Database for recurrent cervical carcinoma

Every month we try and update this database with for recurrent cervical carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer	NCT00217633	Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Recurrent Cervi...	Conventional Su...	18 Years -	GOG Foundation
Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer	NCT00057863	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IVA Cervi... Stage IVB Cervi...	Paclitaxel Oxaliplatin	18 Years -	National Cancer Institute (NCI)
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer	NCT02257528	Cervical Adenoc... Cervical Adenos... Recurrent Cervi... Stage IV Cervic... Stage IVA Cervi... Stage IVB Cervi...	Laboratory Biom... Nivolumab	18 Years -	National Cancer Institute (NCI)
Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy	NCT04188860	Recurrent Cervi... Persistent Adva... Chemotherapy Anti-PD-1 Antib... Immunotherapy	A combination o...	18 Years - 75 Years	Peking Union Medical College Hospital
Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer	NCT00499031	Cervical Squamo... Recurrent Cervi...	Cetuximab	18 Years -	GOG Foundation
Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer	NCT01266460	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi...	Attenuated Live... Laboratory Biom...	18 Years -	GOG Foundation
the Re-irradiation of Recurrent Cervical Cancer by IMRT	NCT03170570	Cervical Cancer Radiation Toxic... Recurrent Cervi...	intensity-modul...	18 Years - 65 Years	Sun Yat-sen University
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer	NCT02257528	Cervical Adenoc... Cervical Adenos... Recurrent Cervi... Stage IV Cervic... Stage IVA Cervi... Stage IVB Cervi...	Laboratory Biom... Nivolumab	18 Years -	National Cancer Institute (NCI)
Dostarlimab and Cobolimab in Advanced Cervical Cancer	NCT06238635	Cervical Cancer Advanced Cervic... Metastatic Cerv... Metastatic Cerv... Recurrent Cervi...	Dostarlimab Cobolimab	18 Years -	Beth Israel Deaconess Medical Center
Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial	NCT05290935	Recurrent Cervi... Persistent Adva... Chemotherapy Immune Checkpoi... Anti-PD-1 Antib... Albumin-bound P...	Anti-PD-1 antib... Albumin-bound p...	18 Years - 75 Years	Peking Union Medical College Hospital
Collecting Tumor Samples From Patients With Gynecological Tumors	NCT00897442	Borderline Ovar... Borderline Ovar... Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Childhood Embry... Childhood Malig... Endometrioid St... Gestational Tro... Malignant Mesot... Malignant Ovari... Melanoma Neoplasm of Unc... Ovarian Brenner... Ovarian Clear C... Ovarian Serous ... Paget Disease o... Recurrent Cervi... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Recurrent Vagin... Recurrent Vulva... Stage I Ovarian... Stage I Uterine... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IA Fallop... Stage IA Ovaria... Stage IA Ovaria... Stage IB Cervic... Stage IB Fallop... Stage IB Ovaria... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage IC Ovaria... Stage II Ovaria... Stage II Uterin... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIA Fallo... Stage IIA Ovari... Stage IIA Ovari... Stage IIB Cervi... Stage IIB Fallo... Stage IIB Ovari... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage IIC Ovari... Stage III Borde... Stage III Cervi... Stage III Uteri... Stage III Vagin... Stage III Vulva... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Border... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... Stage IVB Vulva... Uterine Corpus ... Uterine Corpus ... Vulvar Squamous...	Laboratory Biom...	-	GOG Foundation
Donafenib for Recurrent Cervical Cancer	NCT05310331	Targeted Therap... Chemotherapy Recurrent Cervi... Metastatic Cerv... Persistent Adva... Survival Outcom... Adverse Effect	Donafenib combi...	18 Years - 75 Years	Peking Union Medical College Hospital
Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer	NCT04574635	Cervical Adenos... Cervical Squamo... Infiltrating Ce... Metastatic Cerv... Recurrent Cervi... Stage I Cervica... Stage IA Cervic... Stage IA1 Cervi... Stage IA2 Cervi... Stage IB Cervic... Stage IB1 Cervi... Stage IB2 Cervi... Stage IB3 Cervi... Stage II Cervic... Stage IIA Cervi... Stage IIA1 Cerv... Stage IIA2 Cerv... Stage IIB Cervi... Stage III Cervi... Stage IIIA Cerv... Stage IIIB Cerv... Stage IIIC Cerv... Stage IIIC1 Cer... Stage IIIC2 Cer... Stage IV Cervic... Stage IVA Cervi... Stage IVB Cervi...	Biospecimen Col...	18 Years -	Mayo Clinic
Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer	NCT00057863	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IVA Cervi... Stage IVB Cervi...	Paclitaxel Oxaliplatin	18 Years -	National Cancer Institute (NCI)
Collecting Tumor Samples From Patients With Gynecological Tumors	NCT00897442	Borderline Ovar... Borderline Ovar... Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Childhood Embry... Childhood Malig... Endometrioid St... Gestational Tro... Malignant Mesot... Malignant Ovari... Melanoma Neoplasm of Unc... Ovarian Brenner... Ovarian Clear C... Ovarian Serous ... Paget Disease o... Recurrent Cervi... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Recurrent Vagin... Recurrent Vulva... Stage I Ovarian... Stage I Uterine... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IA Fallop... Stage IA Ovaria... Stage IA Ovaria... Stage IB Cervic... Stage IB Fallop... Stage IB Ovaria... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage IC Ovaria... Stage II Ovaria... Stage II Uterin... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIA Fallo... Stage IIA Ovari... Stage IIA Ovari... Stage IIB Cervi... Stage IIB Fallo... Stage IIB Ovari... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage IIC Ovari... Stage III Borde... Stage III Cervi... Stage III Uteri... Stage III Vagin... Stage III Vulva... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Border... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... Stage IVB Vulva... Uterine Corpus ... Uterine Corpus ... Vulvar Squamous...	Laboratory Biom...	-	GOG Foundation
PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer	NCT05310305	Immune Checkpoi... Anti-programmed... Radiotherapy Recurrent Cervi... Metastatic Cerv... Persistent Adva... Objective Remis... Progression-fre... Overall Surviva... Severe Adverse ...	Radiotherapy fo...	18 Years -	Peking Union Medical College Hospital
Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer	NCT01267253	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Persistent Dise... Recurrent Cervi...	Brivanib Alanin... Laboratory Biom...	18 Years -	GOG Foundation
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers	NCT03968406	Malignant Femal... Recurrent Cervi... Recurrent Endom... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Recurrent Vagin... Stage IV Cervic... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IV Vagina... Stage IVA Cervi... Stage IVA Fallo... Stage IVA Ovari... Stage IVA Prima... Stage IVA Uteri... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Fallo... Stage IVB Ovari... Stage IVB Prima... Stage IVB Uteri... Stage IVB Vagin...	Quality-of-Life... Radiation Thera... Talazoparib	18 Years -	M.D. Anderson Cancer Center
Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer	NCT00217633	Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Recurrent Cervi...	Conventional Su...	18 Years -	GOG Foundation
Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer	NCT00257348	Cervical Cancer	Capecitabine Docetaxel	18 Years -	University of California, Irvine
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer	NCT01266447	Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Recurrent Cervi... Stage III Cervi... Stage IVA Cervi... Stage IVB Cervi...	Filgrastim Laboratory Biom... Pegfilgrastim Topotecan Hydro... Veliparib	18 Years -	National Cancer Institute (NCI)
Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer	NCT03277482	Recurrent Gynec... Metastatic Cerv... Metastatic Ovar... Metastatic Vagi... Metastatic Vulv... Metastatic Endo... Recurrent Cervi... Recurrent Ovari... Recurrent Vagin... Recurrent Vulva... Recurrent Endom...	Durvalumab Tremelimumab Radiation Thera...	18 Years -	Dana-Farber Cancer Institute
Dostarlimab and Cobolimab in Advanced Cervical Cancer	NCT06238635	Cervical Cancer Advanced Cervic... Metastatic Cerv... Metastatic Cerv... Recurrent Cervi...	Dostarlimab Cobolimab	18 Years -	Beth Israel Deaconess Medical Center
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer	NCT01992861	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Cervical Undiff... Recurrent Cervi... Stage IB2 Cervi... Stage II Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage IIIA Cerv... Stage IIIB Cerv... Stage IVA Cervi...	Computed Tomogr... Diffusion Weigh... Dynamic Contras... Fludeoxyglucose... Magnetic Resona... Positron Emissi...	18 Years -	University of Washington
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer	NCT01098630	Recurrent Cervi... Recurrent Uteri... Recurrent Uteri... Stage I Uterine... Stage I Uterine... Stage IA Cervic... Stage IB Cervic... Stage II Uterin... Stage II Uterin... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Uteri... Stage III Uteri... Stage IV Uterin... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi...	Medical Chart R... Questionnaire A...	-	GOG Foundation
Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers	NCT03345784	Cervical Carcin... Endometrioid Ad... Malignant Femal... Recurrent Cervi... Stage I Uterine... Stage I Vaginal... Stage IA Uterin... Stage IB Cervic... Stage IB Uterin... Stage IB2 Cervi... Stage II Cervic... Stage II Uterin... Stage II Vagina... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Uteri... Stage III Vagin... Stage IIIA Cerv... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Uter... Stage IIIC Uter... Vaginal Carcino...	Adavosertib Cisplatin External Beam R...	18 Years -	National Cancer Institute (NCI)
Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery	NCT01026792	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IIIA Cerv... Stage IIIB Cerv... Stage IVA Cervi... Stage IVB Cervi...	Temsirolimus Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma	NCT04664244	Recurrent Cervi... Radiotherapy Epidermal Growt... Nimotuzumab Objective Respo... Progression-fre... Overall Surviva...	Combination of ...	18 Years -	Peking Union Medical College Hospital
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix	NCT00064077	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IVB Cervi...	Cisplatin Gemcitabine Hyd... Paclitaxel Quality-of-Life... Topotecan Hydro... Vinorelbine Tar...	18 Years -	GOG Foundation
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer	NCT01992861	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Cervical Undiff... Recurrent Cervi... Stage IB2 Cervi... Stage II Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage IIIA Cerv... Stage IIIB Cerv... Stage IVA Cervi...	Computed Tomogr... Diffusion Weigh... Dynamic Contras... Fludeoxyglucose... Magnetic Resona... Positron Emissi...	18 Years -	University of Washington
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis	NCT03508570	Malignant Perit... Malignant Retro... Metastatic Cerv... Metastatic Endo... Metastatic Fall... Metastatic Mali... Metastatic Ovar... Metastatic Prim... Peritoneal Carc... Platinum-Refrac... Platinum-Refrac... Platinum-Refrac... Platinum-Refrac... Platinum-Resist... Platinum-Resist... Platinum-Resist... Platinum-Resist... Recurrent Cervi... Recurrent Endom... Recurrent Fallo... Recurrent Malig... Recurrent Ovari... Recurrent Prima... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IVA Fallo... Stage IVA Ovari... Stage IVA Prima... Stage IVB Cervi... Stage IVB Fallo... Stage IVB Ovari... Stage IVB Prima... Stage IVB Uteri...	Ipilimumab Laboratory Biom... Nivolumab Pharmacokinetic...	18 Years -	M.D. Anderson Cancer Center
the Re-irradiation of Recurrent Cervical Cancer by IMRT	NCT03170570	Cervical Cancer Radiation Toxic... Recurrent Cervi...	intensity-modul...	18 Years - 65 Years	Sun Yat-sen University
Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer	NCT01281852	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IVB Cervi...	Cisplatin Laboratory Biom... Paclitaxel Veliparib	18 Years -	National Cancer Institute (NCI)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	NCT02465060	Advanced Lympho... Advanced Malign... Bladder Carcino... Breast Carcinom... Cervical Carcin... Colon Carcinoma Colorectal Carc... Endometrial Car... Esophageal Carc... Gastric Carcino... Glioma Head and Neck C... Hematopoietic a... Kidney Carcinom... Liver Carcinoma Lung Carcinoma Lymphoma Malignant Uteri... Melanoma Multiple Myelom... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... Rectal Carcinom... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Color... Recurrent Esoph... Recurrent Gastr... Recurrent Gliom... Recurrent Head ... Recurrent Liver... Recurrent Lung ... Recurrent Lymph... Recurrent Malig... Recurrent Melan... Recurrent Multi... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Skin ... Recurrent Thyro... Recurrent Uteri... Refractory Lymp... Refractory Mali... Refractory Mult... Skin Carcinoma Thyroid Gland C... Uterine Corpus ...	Adavosertib Afatinib Afatinib Dimale... Binimetinib Biopsy Biospecimen Col... Capivasertib Computed Tomogr... Copanlisib Copanlisib Hydr... Crizotinib Cytology Specim... Dabrafenib Dabrafenib Mesy... Dasatinib Defactinib Defactinib Hydr... Echocardiograph... Erdafitinib Fexagratinib Ipatasertib Laboratory Biom... Larotrectinib Larotrectinib S... Magnetic Resona... Multigated Acqu... Nivolumab Osimertinib Palbociclib Pertuzumab PI3K-beta Inhib... Radiologic Exam... Radionuclide Im... Relatlimab Sapanisertib Sunitinib Malat... Taselisib Trametinib Trastuzumab Trastuzumab Emt... Ulixertinib Vismodegib	18 Years -	National Cancer Institute (NCI)
Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer	NCT04574635	Cervical Adenos... Cervical Squamo... Infiltrating Ce... Metastatic Cerv... Recurrent Cervi... Stage I Cervica... Stage IA Cervic... Stage IA1 Cervi... Stage IA2 Cervi... Stage IB Cervic... Stage IB1 Cervi... Stage IB2 Cervi... Stage IB3 Cervi... Stage II Cervic... Stage IIA Cervi... Stage IIA1 Cerv... Stage IIA2 Cerv... Stage IIB Cervi... Stage III Cervi... Stage IIIA Cerv... Stage IIIB Cerv... Stage IIIC Cerv... Stage IIIC1 Cer... Stage IIIC2 Cer... Stage IV Cervic... Stage IVA Cervi... Stage IVB Cervi...	Biospecimen Col...	18 Years -	Mayo Clinic
Tislelizumab and Radiotherapy for Recurrent Cervical Cancer	NCT05310383	Recurrent Cervi... Metastatic Cerv... Persistent Cerv... Radiotherapy Immunotherapy Anti-programmed... Immune Checkpoi... Tislelizumab Objective Respo... Survival Outcom...	Tislelizumab pl...	18 Years -	Peking Union Medical College Hospital
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies	NCT02578888	Cervical Carcin... Ovarian Carcino... Primary Periton... Recurrent Cervi... Recurrent Ovari... Recurrent Uteri... Recurrent Vulva... Uterine Corpus ... Vulvar Carcinom... Peritoneal Neop...	Palliative Ther... Palliative Ther...	-	Albert Einstein College of Medicine
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis	NCT03508570	Malignant Perit... Malignant Retro... Metastatic Cerv... Metastatic Endo... Metastatic Fall... Metastatic Mali... Metastatic Ovar... Metastatic Prim... Peritoneal Carc... Platinum-Refrac... Platinum-Refrac... Platinum-Refrac... Platinum-Refrac... Platinum-Resist... Platinum-Resist... Platinum-Resist... Platinum-Resist... Recurrent Cervi... Recurrent Endom... Recurrent Fallo... Recurrent Malig... Recurrent Ovari... Recurrent Prima... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IVA Fallo... Stage IVA Ovari... Stage IVA Prima... Stage IVB Cervi... Stage IVB Fallo... Stage IVB Ovari... Stage IVB Prima... Stage IVB Uteri...	Ipilimumab Laboratory Biom... Nivolumab Pharmacokinetic...	18 Years -	M.D. Anderson Cancer Center
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer	NCT00803062	Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IVB Cervi...	Bevacizumab Cisplatin Laboratory Biom... Paclitaxel Quality-of-Life... Questionnaire A... Topotecan Hydro...	18 Years -	National Cancer Institute (NCI)
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer	NCT00309959	Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Recurrent Cervi...	Paclitaxel Albu... Laboratory Biom...	-	GOG Foundation
Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas	NCT04635956	Chemotherapy Anti-pd-1 Antib... Cervical Neuroe... Adverse Drug Ev... Recurrent Cervi... Advanced Cervic... Objective Respo...	Drug therapy	18 Years -	Peking Union Medical College Hospital
Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer	NCT01693783	Cervical Adenoc... Cervical Squamo... Human Papilloma... Recurrent Cervi... Stage IVA Cervi... Stage IVB Cervi...	Ipilimumab Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
First-line Chemotherapy for Recurrent Cervical Cancer	NCT04188847	Recurrent Cervi... Persistent Adva... Chemotherapy Vascular Endoth... Apatinib Targeted Therap...	Chemotherapy pl...	18 Years - 75 Years	Peking Union Medical College Hospital
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations	NCT02646319	Advanced Malign... Cervical Squamo... Endometrial Car... Malignant Uteri... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Head ... Recurrent Malig... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Solid Neoplasm Stage III Bladd... Stage III Prost... Stage III Renal... Stage IIIA Brea... Stage IIIA Cerv... Stage IIIA Ovar... Stage IIIB Brea... Stage IIIB Cerv... Stage IIIB Ovar... Stage IIIC Brea... Stage IIIC Ovar... Stage IV Breast... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IVA Bladd... Stage IVA Cervi... Stage IVB Bladd... Stage IVB Cervi...	Laboratory Biom... Nanoparticle Al... Quality-of-Life...	18 Years -	Mayo Clinic
Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer	NCT00041093	Cervical Squamo... Recurrent Cervi...	Docetaxel	-	GOG Foundation
Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma	NCT04664244	Recurrent Cervi... Radiotherapy Epidermal Growt... Nimotuzumab Objective Respo... Progression-fre... Overall Surviva...	Combination of ...	18 Years -	Peking Union Medical College Hospital

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: